This inventor holds 1 USPTO granted patent. Top assignees: The State University of New York, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2024.
Company Filing History:
1 out of 2,044 
1 out of 3,693 
Years Active: 2024
Title: Lorna Erlich: Innovator in Viral Inhibition
Introduction
Lorna Erlich is a notable inventor based in Shoreham, NY (US). She has made significant contributions to the field of virology through her innovative research and patent work. Her expertise lies in developing methods to inhibit viruses, showcasing her commitment to advancing medical science.
Latest Patents
Lorna Erlich holds a patent titled "Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction." This invention provides a method for inhibiting the release of a virus from a cell. The method involves contacting the cell with a compound that binds to an ubiquitin E2 variant (UEV) domain of a cellular polypeptide, effectively disrupting the binding of the cellular polypeptide to ubiquitin. She has 1 patent to her name, reflecting her innovative contributions to the field.
Career Highlights
Throughout her career, Lorna has worked with esteemed institutions, including the State University of New York and the United States Department of Health and Human Services. Her work has been instrumental in advancing our understanding of viral mechanisms and potential therapeutic interventions.
Collaborations
Lorna has collaborated with notable colleagues such as Nico Tjandra and Madeleine Davison. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Lorna Erlich's work in viral inhibition exemplifies the impact of innovative research in the medical field. Her contributions continue to pave the way for advancements in virology and therapeutic strategies.